Cloned (Comment) | Organism |
---|---|
recombinant stable expression of mutant and wild-type SPTLC2 subunit in HEK293 cells | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
S384A | a subunit SPTLC2 phosphorylation site mutant, the mutation has no effect n enzyme activity | Homo sapiens |
S384D | a subunit SPTLC2 phosphorylation site mutant, the mutation is associated with increased 1-deoxysphingolipids formation | Homo sapiens |
S384E | a subunit SPTLC2 phosphorylation site mutant, the mutation is not associated with increased 1-deoxysphingolipids formation | Homo sapiens |
S384F | a subunit SPTLC2 phosphorylation site mutant, naturally occuring in hereditary sensory and autonomic neuropathy type I, HSAN1, families. Affected patients showed elevated plasma 1-deoxysphingolipid levels and expression of the S384F mutant in HEK-293 cells increased 1-deoxysphingolipid formation | Homo sapiens |
Y387F | a subunit SPTLC2 phosphorylation site mutant, the mutation has no effect n enzyme activity | Homo sapiens |
Y387F/S384A | a subunit SPTLC2 phosphorylation sites mutant, the mutation has no effect n enzyme activity | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Homo sapiens | 1-deoxysphingolipids are atypical sphingolipids that are formed by the enzyme serine palmitoyltransferase due to a promiscuous use of L-alanine over its canonical substrate L-serine. Wild-type SPT forms 1-deoxysphingolipids under certain conditions, and elevated levels are found in individuals with the metabolic syndrome and diabetes | ? | - |
? | |
palmitoyl-CoA + L-alanine | Homo sapiens | wild-type enzyme can metabolize L-alanine under certain conditions | CoA + (2S)-2-aminooctadecan-3-one + CO2 | - |
? | |
palmitoyl-CoA + L-serine | Homo sapiens | - |
CoA + 3-dehydro-D-sphinganine + CO2 | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | O15270 | subunit SPTLC2; British families | - |
Posttranslational Modification | Comment | Organism |
---|---|---|
phosphoprotein | the enzyme is phosphorylated at S284 regulating its substrate specificity | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | 1-deoxysphingolipids are atypical sphingolipids that are formed by the enzyme serine palmitoyltransferase due to a promiscuous use of L-alanine over its canonical substrate L-serine. Wild-type SPT forms 1-deoxysphingolipids under certain conditions, and elevated levels are found in individuals with the metabolic syndrome and diabetes | Homo sapiens | ? | - |
? | |
palmitoyl-CoA + L-alanine | wild-type enzyme can metabolize L-alanine under certain conditions | Homo sapiens | CoA + (2S)-2-aminooctadecan-3-one + CO2 | - |
? | |
palmitoyl-CoA + L-serine | - |
Homo sapiens | CoA + 3-dehydro-D-sphinganine + CO2 | - |
? |
Synonyms | Comment | Organism |
---|---|---|
serine palmitoyltransferase | - |
Homo sapiens |
SPT | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
8 | - |
assay at | Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | the S384D but not the S384E mutation is associated with increased 1-deoxysphingolipids formation | Homo sapiens |
metabolism | several mutations in SPT are associated with the hereditary sensory and autonomic neuropathy type I, HSAN1. Wild-type SPT forms 1-deoxysphingolipids under certain conditions, and elevated levels are found in individuals with the metabolic syndrome and diabetes | Homo sapiens |
physiological function | specificity of wild-type SPT might by dynamically regulated by a phosphorylation at position S384 | Homo sapiens |